PLUS PHARMA
ActiveSummary
PLUS PHARMA has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€151,542) and a net result of -€1,825. Equity remains stable across the filed financial years (±1.9% per year). The computed 12-month bankruptcy probability is 0.9% (low).
Financials · financial year 2025, unclassified schema
2025 annual accounts filed late (2 days) Filed on 2 February 2026, deadline 31 January 2026 (7 months after the close on 30 June 2025, Companies Code art. 3:10). Source: NBB, 2026-00026439.
2021 to 2025, 5 financial years 2019 to 2025, 7 financial years
The operating result stays negative: a loss of €1,330 in 2025 against €1,356 in 2024; the loss shrinks.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Use the arrow keys on the chart for the figures per year.
Peer companies
Historical observationOf the 6,906 companies that looked in July 2024 the way this one looks now, 5.8% went bankrupt within 24 months and 85.4% are still going.
- Micro
- 10 to 20 years old
- negative equity
- a loss of 10% of the balance sheet or more
A further 0.6% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.9% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,906 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6,755 | €1,400 | €1,400 | €1,400 | €1,400 | - | - | - |
| Other operating charges640/8 | - | - | - | €360 | €348 | €445 | €408 | ▼ 8.5% |
| Gross operating margin9900 | -€1,795 | -€1,234 | -€1,252 | -€493 | -€862 | -€911 | -€923 | ▼ 1.3% |
| Operating profit (loss)9901 | -€8,898 | -€2,634 | -€3,000 | -€2,253 | -€2,610 | -€1,356 | -€1,330 | ▲ 1.9% |
| Financial charges65/66B | - | - | - | €453 | €486 | €486 | €495 | ▲ 1.9% |
| Recurring financial charges65 | €354 | €286 | €351 | €453 | €486 | €486 | €495 | ▲ 1.9% |
| Profit (loss) for the period before taxes9903 | -€9,252 | -€2,920 | -€3,351 | -€2,706 | -€3,096 | -€1,842 | -€1,825 | ▲ 0.9% |
| Profit (loss) for the period9904 | -€9,252 | -€2,920 | -€3,351 | -€2,706 | -€3,096 | -€1,842 | -€1,825 | ▲ 0.9% |
| Profit (loss) for the period to be appropriated9905 | -€9,252 | -€2,920 | -€3,351 | -€2,706 | -€3,096 | -€1,842 | -€1,825 | ▲ 0.9% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €15,681 | €12,028 | €9,440 | €5,971 | €2,979 | €1,838 | €1,008 | ▼ 45.1% |
| Fixed assets21/28 | €5,600 | €4,200 | €2,800 | €1,400 | - | - | - | - |
| Intangible fixed assets21 | €5,600 | €4,200 | €2,800 | €1,400 | - | - | - | - |
| Current assets29/58 | €10,081 | €7,828 | €6,640 | €4,571 | €2,979 | €1,838 | €1,008 | ▼ 45.1% |
| Amounts receivable within one year40/41 | - | - | - | - | - | €524 | €524 | = |
| Other amounts receivable41 | - | - | - | - | - | €524 | €524 | = |
| Cash at bank and in hand54/58 | €10,081 | €7,828 | €6,640 | €4,571 | €2,979 | €1,314 | €484 | ▼ 63.1% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €15,681 | €12,028 | €9,440 | €5,971 | €2,979 | €1,838 | €1,008 | ▼ 45.1% |
| Equity10/15 | -€135,801 | -€138,722 | -€142,072 | -€144,779 | -€147,874 | -€149,717 | -€151,542 | ▼ 1.2% |
| Contributions10/11 | €18,600 | €18,600 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Profit (loss) carried forward14 | -€154,401 | -€157,322 | -€160,672 | -€163,379 | -€166,474 | -€168,317 | -€170,142 | ▼ 1.1% |
| Amounts payable17/49 | €151,482 | €150,750 | €151,512 | €150,750 | €150,854 | €151,555 | €152,550 | ▲ 0.7% |
| Amounts payable within one year42/48 | €151,482 | €150,750 | €150,750 | €150,750 | €150,854 | €151,555 | €152,550 | ▲ 0.7% |
| Trade debts44 | €2,132 | €1,400 | €1,400 | €1,400 | €1,464 | €1,400 | €2,730 | ▲ 95.0% |
| Suppliers440/4 | - | - | - | €1,400 | €1,464 | €1,400 | €2,730 | ▲ 95.0% |
| Other amounts payable47/48 | - | - | - | €149,350 | €149,390 | €150,155 | €149,820 | ▼ 0.2% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€9,252 | -€2,920 | -€3,351 | -€2,706 | -€3,096 | -€1,842 | -€1,825 | ▲ 0.9% |
| + Depreciation and write-downs630 | €6,755 | €1,400 | €1,400 | €1,400 | €1,400 | - | - | - |
| Operating cash flow (approximation) | -€2,497 | -€1,520 | -€1,951 | -€1,306 | -€1,696 | -€1,842 | -€1,825 | ▲ 0.9% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | - | - | - | - |
| Change in cash | - | -€2,252 | -€1,188 | -€2,069 | -€1,592 | -€1,665 | -€830 | ▲ 50.1% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 16 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 30-06-2025 | unclassified schema | 02-02-2026 | 2026-00026439 |
| 30-06-2024 | unclassified schema | 10-12-2024 | 2024-00613050 |
| 30-06-2023 | unclassified schema | 28-02-2024 | 2024-00035692 |
| 30-06-2022 | unclassified schema | 30-01-2023 | 2023-00008547 |
| 30-06-2021 | unclassified schema | 25-01-2022 | 2022-01800535 |
| 30-06-2020 | abbreviated format | 14-12-2020 | 2020-75700100 |
| 30-06-2019 | abbreviated format | 10-01-2020 | 2020-00700364 |
| 30-06-2018 | abbreviated format | 28-02-2019 | 2019-06000303 |
| 30-06-2017 | abbreviated format | 03-02-2018 | 2018-04300347 |
| 30-06-2016 | full format | 27-02-2017 | 2017-05700317 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.